Mediamedic

Dr. William Oh, a distinguished medical oncologist specializing in genitourinary malignancies, has recently been appointed as the Director of Precision Medicine for Yale Cancer Center and Smilow Cancer Hospital. In this role, Dr. Oh is spearheading initiatives to integrate advanced genomic and molecular data into personalized cancer treatment plans, aiming to enhance patient outcomes through tailored therapies.Prior to this appointment, Dr. Oh served as the Chief Medical Officer for the Prostate Cancer Foundation, where he focused on addressing barriers to prostate cancer care and implementing strategies to reduce mortality rates. His leadership in precision medicine and commitment to advancing cancer research continue to inspire the oncology community and offer hope to patients worldwide.#OncologyLeadership #PrecisionMedicine #WilliamOh #CancerResearch #MedicalInnovation #PatientCare #MediaMedic

#SABCS2024 Dr. Baoliang Guo Analyzes Surgery Timing in Breast Cancer Patients Aged 70+ At SABCS 2024, Dr. Baoliang Guo discussed findings from an EBCTCG meta-analysis on immediate versus delayed surgery in operable breast cancer patients aged 70+. The study emphasizes the benefits of immediate surgery in reducing recurrence and improving long-term survival in this population. #BreastCancer #ElderlyPatients #SurgeryTiming #CancerResearch #OncologyCare #TreatmentStrategies

Media Medic 2024: A Year of Progress Thank you to the experts who shared their insights, driving advancements in oncology, hematology, infectious diseases, and hepatology. Here's to continued impact in 2025! #MediaMedic #ExpertInsights

A Year of Expert Insights: Media Medic in 2024 🎙️ This year, Media Medic had the privilege of speaking with remarkable experts across oncology, hematology, infectious diseases, and hepatology. We extend our heartfelt thanks to these leaders for generously sharing their knowledge, shaping important discussions, and contributing to advancements in patient care. Your dedication and expertise inspire progress and bring hope to countless patients worldwide. It has been an honor to collaborate with you and amplify your voices throughout 2024. As we look forward to the coming year, we remain committed to highlighting the work of medical professionals making a difference every day. #MediaMedic #Oncology #Hematology #InfectiousDiseases #Hepatology #ExpertInsights #MedicalAdvancements

Unveiling Highlights from the #CAHON Winter Symposium 2024! On December 6, CAHON brought together a distinguished group of hematology and oncology experts at The University Club Atop Symphony Tower in San Diego, CA. The symposium was a celebration of collaboration, innovation, and mentorship. 💡 Event Highlights: 🌟 Dr. Jing-Zhou Hou: Opened the symposium with a powerful message about CAHON’s mission. 🌟 Dr. Liang Deng: Newly appointed CAHON President (2024–2026), shared exciting plans, including a new media platform and newsletter to expand CAHON's global impact. 🌟 Dr. Robert Negrin (ASH President-Elect): Delivered a keynote reflecting on 25 years of research into graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL), presenting strategies for improving transplantation outcomes. 🌟 Dr. Brian Durie: Provided groundbreaking insights on minimal residual disease (MRD) as a clinical endpoint and immune dysfunction in multiple myeloma patients. 🌟 Dr. Hong Zheng: Presented the Young Investigator Awards, honoring outstanding research and showcasing the future of hematology and oncology. 🌟 Networking & Mentorship: The symposium offered fellows and residents the opportunity to engage with senior CAHON members, fostering meaningful conversations about academic careers and clinical practice. This inspiring event highlighted CAHON's commitment to bridging healthcare disparities, driving innovation, and mentoring the next generation of medical professionals. 📢 Read the full summary here: CAHON Winter Symposium 2024 Summary 💬 What are your thoughts on the advancements in hematology and oncology? Let us know in the comments! #CAHON2024 #OncologyFrontier #HematologyFrontier #MedicalInnovation #MentorshipMatters #HealthcareLeadership #YoungInvestigators #GlobalHealth

Professor Sophia Ononye, PhD MPH MBA is setting new standards in leadership and innovation 💫 As a scientific storyteller and a champion for diversity in STEM, she recently joined Cohort 8 of the prestigious BLCK VC Black Venture Institute, collaborating with 60+ accomplished professionals to reshape the venture capital landscape. Guided by esteemed leaders like Professor Toby Stuart and Frederik Groce, she’s bridging the gap between academic rigor and real-world impact in venture capital. Recognized by ForbesBLK and featured in Inc. Magazine, her story as a Nigerian-American entrepreneur inspires a global audience. Her work with the Larta Institute, where she champions healthcare innovation and sustainable solutions, underscores her ability to turn vision into action. Sophia Ononye, PhD MPH MBA 's journey is a powerful reminder that diversity is a catalyst for progress. Let’s celebrate her groundbreaking efforts and support the mission to create a future where innovation reflects the richness of our world. #DiversityInSTEM #Innovation #Leadership #VentureCapital #AmplifyingVoices

#SABCS2024 Rethinking Dosing: Clinical Symposium on Optimizing Regimens in Breast Oncology At SABCS 2024, experts explored advancements in dose optimization for breast cancer therapies, shifting from maximum tolerated doses to individualized strategies for targeted treatments, redefining precision oncology practices. #BreastOncology #DoseOptimization #CancerTreatment #PrecisionMedicine #OncologyInnovation

#ESMOAsia2024 Prof. Zhi Peng Highlights DESTINY-Gastric06: Transforming HER2-Positive Gastric Cancer Treatment At ESMO Asia 2024, Prof. Zhi Peng from Peking University Cancer Hospital unveiled key findings from the DESTINY-Gastric06 study. The results underscore the transformative role of antibody-drug conjugates (ADCs) in advancing treatment for HER2-positive gastric cancer. #GastricCancer #HER2Positive #DESTINYGastric06 #AntibodyDrugConjugates #OncologyInnovation #CancerResearch

Exploring Colonic EMR Techniques with Professors Thomas Rösch and Michael J. Bourke In the latest episode of the Endoscopy Essentials video podcast, released on December 20, 2024, host Professor Thomas Rösch welcomes Professor Michael J. Bourke, a renowned expert from Sydney, to discuss advanced approaches in gastrointestinal endoscopy. Key Highlights from Episode 7: 🟢 Colonic Endoscopic Mucosal Resection (EMR): This episode is the seventh installment in a series dedicated to colonic EMR. Professor Bourke shares his expertise on treatment allocation, focusing on the decision-making process between hot and cold EMR techniques for colonic polyps. The discussion provides valuable insights into optimizing patient outcomes by selecting the most suitable approach. 🟢 Practical Insights: Listeners gain knowledge about polyp assessment, risk stratification, and technical considerations that influence the choice of EMR techniques. The conversation offers actionable guidance for endoscopists aiming to refine their therapeutic strategies. This engaging discussion is an excellent resource for gastroenterologists and endoscopists seeking to deepen their understanding of colonic EMR. Catch this episode and explore earlier ones on the Endoscopy Essentials platform: https://lnkd.in/dvERqNu4 #EndoscopyEssentials #Gastroenterology #ColonicEMR #ThomasRösch #MichaelBourke #MedicalPodcast

#SABCS2024Broadcast | Prof. Yongmei Yin and Prof. Junjie Li Highlight Simplified Treatments and AI Innovations in Breast Cancer Care At SABCS 2024, Prof. Yongmei Yin and Prof. Junjie Li discussed advances in early breast cancer management, including findings on tamoxifen for low-risk DCIS, the INSEMA trial on avoiding SLND, and AI-driven approaches to breast cancer risk screening. #SABCS2024 #BreastCancer #AIinMedicine #EarlyDetection #DCIS #BreastConservingSurgery #OncologyInnovation #CancerResearch